The Royal Marsden NHS Foundation Trust on Twitter: "Huge congratulations Professors David Cunningham, Johann De Bono, Kevin Harrington, Nicholas Turner, Mitch Dowsett, James Larkin! #HighlyCited2021" / Twitter
Will Immunotherapy Put Head and Neck Surgeons Out of Business? – Semon Lectures
SAB and I-O AB - T3 Pharma
Kevin Harrington (@kevhar6763) / Twitter
Potential of immunotherapy in head and neck cancer | VJOncology
Immunotherapy: changing the face of melanoma treatment | TRM CancerBRC
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
My final lifeline" | The Biomedical Scientist Magazine of the IBMS
Potential of immunotherapy in head and neck cancer | VJOncology
Professor Kevin Harrington - The Institute of Cancer Research, London
GM herpes virus fights advanced cancers
Professor Kevin Harrington - The Institute of Cancer Research, London
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
Scientific Advisory Board | Nanobiotix
Radiotherapy Theme on Vimeo
Pablo NENCLARES | Research Fellow | Clinical Oncologist | Head and Neck Unit / Radiotherapy and Imaging Team | Research profile
Royal Marsden staff among world's top influential researchers | The Royal Marsden Cancer Charity
Professor Kevin Harrington - The Institute of Cancer Research, London
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Cancer: Scientists aim to double survival within a decade | The Independent
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
World-first centre for recurrent head & neck cancer - Professor Christopher Nutting Oncology
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
Professor Kevin Harrington | The Royal Marsden
